Athenahealth (ATHN) Misses Q1 EPS by 15c; Lowers Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
athenahealth (ATHN) PT Lowered to $123 at UBS
May 1, 2017 10:08 AM EDTUBS lowered its price target on athenahealth (NASDAQ: ATHN) to $123.00 (from $140.00) while maintaining a Buy rating.
UBS reduced revenue estimates, with FY17 revenues down from $1.29Bn to $1.22Bn and FY18 revenues down from $1.50Bn to $1.41Bn. FY17 EPS was also reduced from $2.44 to $2.12 and FY18 EPS from $3.05 to $2.56.
... Moreathenahealth (ATHN) PT Lowered to $118 at Cantor Fitzgerald Following 1Q
April 28, 2017 11:13 AM EDTCantor Fitzgerald lowered its price target on athenahealth (NASDAQ: ATHN) to $118.00 (from $135.00) while maintaining a Overweight rating. 1Q17 revenue was $285 million vs. estimates of $300 million. Revenue grew 11% year over year. Adjusted EPS was $0.32 vs. FactSet consensus of $0.46.
Bookings are now expected to be $350-400... More
